Sign In
Buy LLY
$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
Eli Lilly and Company (LLY) Projected to Release Earnings on Wednesday
03:42am, Tuesday, 04'th Aug 2026
Eli Lilly and Company (NYSE: LLY - Get Free Report) is projected to announce its Q2 2026 results before the market opens on Wednesday, August 5th. Analysts expect Eli Lilly and Company to post earning
JPMorgan names 3 stocks worth buying ahead of August earnings
11:16pm, Monday, 03'rd Aug 2026
US stock market is entering August against a turbulent backdrop, featuring continued Iran-driven volatility in oil prices and an ongoing earnings season. Plus, investors are still processing the recen
Eli Lilly to offer early access to next-gen obesity drug to some patients
06:30pm, Monday, 03'rd Aug 2026
Eli Lilly said on Monday it would allow a limited number of patients to have early access to its experimental obesity drug, retatrutide, before its U.S. FDA approval.
5 Things to Know Before the Stock Market Opens on Monday
08:10am, Monday, 03'rd Aug 2026
Stock futures are pointing to a higher open to kick off August trading as investors look ahead to a packed week of earnings reports; oil prices are tumbling after the U.S. paused strikes on Iran over
INDIANAPOLIS, Aug. 3, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to olomorasi
Eli Lilly and Company $LLY is First National Bank of Mount Dora Trust Investment Services’ 9th Largest Position
04:17am, Monday, 03'rd Aug 2026
First National Bank of Mount Dora Trust Investment Services trimmed its position in Eli Lilly and Company (NYSE: LLY) by 21.3% during the first quarter, according to the company in its most recent 13F
Obesity battle heats up again as Novo claws way back into race with Lilly
01:02am, Monday, 03'rd Aug 2026
Novo Nordisk investors have found little cause for optimism during a bruising two-year period of profit warnings, leadership upheaval and a sliding share price as rival Eli Lilly streaked ahead. No
Jobs Report, Palantir, AMD, SpaceX, Eli Lilly, and More to Watch This Week
02:00pm, Sunday, 02'nd Aug 2026
In another heavy earnings week, we'll also see reports from McDonald's, Disney, Uber, Devon Energy, and more.
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
07:55am, Sunday, 02'nd Aug 2026
Abbott Laboratories maintains a diversified business model spanning diagnostics, medical devices, and nutrition products. Eli Lilly is experiencing rapid growth driven by its dominant presence in the
1,411 Shares in Eli Lilly and Company $LLY Purchased by Axiom Investment Management LLC
03:49am, Saturday, 01'st Aug 2026
Axiom Investment Management LLC acquired a new stake in Eli Lilly and Company (NYSE: LLY) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and E
Novo Nordisk vs Eli Lilly: The Better Buy Before Earnings
01:30pm, Friday, 31'st Jul 2026
Novo Nordisk (NYSE: NVO | NVO Price Prediction) and Eli Lilly (NYSE: LLY) both posted Q1 FY2026 results this spring, and the gap between them keeps widening.
Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed.
01:30pm, Friday, 31'st Jul 2026
Both companies are giants in diabetes and obesity treatments. Lately, Eli Lilly has moved ahead in the obesity segment.
Weight Loss Drug Stocks Novo Nordisk, Eli Lilly Slump Below Key Levels
11:51am, Friday, 31'st Jul 2026
Wegovy and Zepbound makers Novo Nordisk and Eli Lilly faced selling pressure on Friday.
Novo Nordisk Wipes Out $30 Billion In Market Value After Failed Heart Drug Trial
11:15am, Friday, 31'st Jul 2026
$30.7 billion. That's how much was cut from Novo Nordisk's market capitalization as of Friday's share price, lowering from $229.2 billion to $198.5 billion, marking a nearly 69% decline since hitting
Lilly (LLY) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:16am, Friday, 31'st Jul 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Lilly (LLY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarte
